CAS number index
Every CAS Registry Number in our catalogue, sorted numerically. Paste a CAS No. into the search bar to jump straight to the product.
| CAS No. | Substance | Grades |
|---|---|---|
| 184764-13-4 | Montelukast (3S)-Hydroxy Methylketone | 1 |
| 184764-20-3 | Montelukast (3S)-Hydroxy Methoxymethoxy Impurity | 1 |
| 184764-27-0 | Montelukast Methoxymethoxy Impurity | 1 |
| 184866-29-3 | (S)-Lercanidipine Hydrochloride | 1 |
| 184899-80-7 | Desoximetasone EP Impurity F | 1 |
| 184955-21-3 | Tryptophan EP Impurity B | 1 |
| 184972-09-6 | Exemestane EP Impurity B | 1 |
| 184972-11-0 | Exemestane Diol Impurity | 1 |
| 184972-12-1 | Epoxy Exemestane (6 Alpha, Beta Isomer) | 1 |
| 185066-33-5 | Fexofenadine EP Impurity F | 1 |
| 185066-37-9 | Fexofenadine EP Impurity C | 1 |
| 185066-40-4 | 1-Keto Descarboxy 1-Deshydroxy Fexofenadine | 1 |
| 185077-02-5 | 3-Fluoro-4-methylphenylmagnesium bromide solution 0.5 M in THF | 1 |
| 185103-80-4 | Acotiamide Methyl Ether | 1 |
| 185104-11-4 | Acotiamide Hydrochloride | 1 |
| 185105-13-9 | N-(2-(Diisopropylamino)ethyl)-2-(4-hydroxy-2,5-dimethoxybenzamido)thiazole-4-carboxamide | 1 |
| 185105-98-0 | Acotiamide Amide Ester Impurity | 1 |
| 185106-01-8 | 2-(2,4,5-Trimethoxybenzamido)thiazole-4-carboxylic Acid | 1 |
| 185106-05-2 | Ethyl-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxylate | 1 |
| 185106-16-5 | Acotiamide | 1 |
| 185107-79-3 | Secorapamycin B | 1 |
| 185243-69-0 | Entanercept | 1 |
| 185309-32-4 | Bis(7-methyl-1,3,5,7-tetraazabicyclo[3.3.1]nonan-3-yl)methane | 1 |
| 185312-10-1 | N-(1H-Imidazol-2-yl)quinoxalin-6-amine | 1 |
| 185336-12-3 | Irinotecan EP Impurity M | 1 |
| 185340-55-0 | 6-N-Propil-8βmethylthiomethyl thiomethyl Ergoline | 1 |
| 185378-84-1 | 5,8,11,14,17,20-Hexaoxatetracosa-2,22-diyne-1,24-diol | 1 |
| 185411-12-5 | Methyl 3-(trimethylsilyl)-4-pentenoate | 1 |
| 185415-07-0 | Raloxifene 4-Monomethyl Ether | 1 |
| 185416-01-7 | 4-Hydroxy Raloxifene | 1 |
| 185421-27-6 | Agomelatine Dimer Urea | 1 |
| 185425-47-2 | O-Methyl Anidulafungin | 1 |
| 185453-02-5 | O-Desmethyl Tramadol Hydrochloride | 1 |
| 185459-57-8 | Iopromide EP Impurity H | 1 |
| 185460-67-7 | Enrofloxacin N Oxide | 1 |
| 185517-74-2 | (S)-Rasagiline | 1 |
| 185608-75-7 | (R)-Indoxacarb | 1 |
| 185613-69-8 | Betamethasone EP Impurity I | 1 |
| 185613-71-2 | Betamethasone EP Impurity H | 1 |
| 185626-66-8 | Haloperidol Cyclopropyl Derivative | 1 |
| 185672-33-7 | All-rac-alfa-Tocopherol EP Impurity A (Mixture of Diastereomers) | 1 |
| 185802-22-6 | (2S,4S)-2-((R)-1-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-2-methoxy-2-oxoethyl)-5,5-dimethylthiazolidine-4-carboxylic acid | 1 |
| 185804-96-0 | ((2S)-3-((1-Ethyl-2,5-dioxopyrrolidin-3-yl)thio)-2-methylpropanoyl)-L-proline | 1 |
| 185807-29-8 | 11-Ethyl Camptothecin | 1 |
| 185815-56-9 | 2,4-Dicyano-3-(2-methylpropyl)-pentanediamide | 1 |
| 185815-59-2 | 3-Isobutylglutaric Anhydride | 1 |
| 185847-75-0 | N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-(1-(methyl(nitroso)amino)-2-nitrovinyl)nitrous amide | 1 |
| 185901-50-2 | Ligand 29 | 1 |
| 185961-99-3 | Rimegepant Piperidine Nitroso Impurity(STEP-4) | 1 |
| 185990-36-7 | N,N-Dimethyl-d6-formamide | 1 |
| 186023-49-4 | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | 1 |
| 186038-82-4 | 2-Carboxy Ethyl 3 Cyano-5 Methyl Hexanoicacid Ethyl Ester | 1 |
| 186046-81-1 | Fmoc-PNA-C(Bhoc)-OH, 98% | 1 |
| 186046-82-2 | Fmoc-PNA-A(Bhoc)-OH, 98% | 1 |
| 186046-83-3 | Fmoc-PNA-G(Bhoc)-OH, 98% | 1 |
| 186094-00-8 | (+)-(2S,5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt | 1 |
| 186099-81-0 | 17,17-Dimethyl-18-nor-5β-androsta-1,13-dien-3a-ol | 1 |
| 186204-31-9 | 5Beta/6beta-Hydroxy lurasidone | 1 |
| 186204-33-1 | Lurasidone Metabolite 14326 | 1 |
| 186204-35-3 | Lurasidone Trans (R,R) Mesylate | 1 |
| 186204-36-4 | Lurasidone EP Impurity B | 1 |
| 186204-37-5 | Lurasidone EP Impurity B (Methanesulfonate salt) | 1 |
| 186352-97-6 | Montelukast 1,2-Diol | 1 |
| 186377-56-0 | O-Desmethyl Brinzolamide | 1 |
| 186496-59-3 | 5-Fluoro-2-methylphenylmagnesium bromide solution 0.5 M in THF | 1 |
| 186508-94-1 | (3S,5R)-6-Cyano-3,5-dihydroxy-hexanoic Acid tert-Butyl Ester | 1 |
| 186508-95-2 | Atorvastatin Acetonide t-Butyl Ester Side Chain (4S,6R)-Isomer | 1 |
| 186521-85-7 | Sibutramine Impurity J | 1 |
| 186541-49-1 | N,N-Dimethyl-D-glucamine Hydrochloride | 1 |
| 186689-07-6 | 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose, 97% | 1 |
| 186694-12-2 | Carbamazepine Impurity 3 | 1 |
| 186694-22-4 | Oxcarbazepine O-Propan-1-one | 1 |
| 186694-45-1 | (R)-Licarbazepine Acetate | 1 |
| 186792-80-3 | Olanzapine 10-N-glucuronide | 1 |
| 186826-68-6 | (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate | 1 |
| 186826-70-0 | (3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol | 1 |
| 186826-86-8 | Moxifloxacin | 3 |
| 187164-18-7 | (E)-2'-Deschloro Luliconazole | 1 |
| 187164-19-8 | Luliconazole | 1 |
| 187166-40-1 | Spinetoram J | 1 |
| 187227-45-8 | Oseltamivir EP Impurity C | 1 |
| 187235-37-6 | Pretomanid | 1 |
| 187244-73-1 | Methylprednisolone Impurity 8 | 1 |
| 187389-52-2 | Z-VAD-FMK, ≥98% (TLC) | 1 |
| 187393-00-6 | Bemotrizinol | 1 |
| 187393-68-6 | (E)-N-(6-Amino-1,3-diethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-(3,4-dimethoxyphenyl)acrylamide | 1 |
| 187540-01-8 | Terbinafine Impurity C | 1 |
| 187618-60-6 | Fmoc-D-Arg(Pbf)-OH, 98% | 1 |
| 187728-85-4 | Nateglinide EP Impurity G | 1 |
| 187731-34-6 | (R)-Lercanidipine Hydrochloride | 1 |
| 187746-94-7 | 5-Chloro-3-sulfothiophene-2-carboxylic Acid | 1 |
| 187746-97-0 | 5-Chloro-3-sulfinothiophene-2-carboxylic Acid | 1 |
| 187949-02-6 | Albaconazole | 1 |
| 188062-50-2 | Abacavir hemisulfate | 1 |
| 188111-79-7 | (R)-1-Boc-3-Aminopiperidine | 1 |
| 188112-75-6 | Amoxicillin EP Impurity G | 1 |
| 188113-72-6 | Dehydro-eletriptan | 1 |
| 188116-07-6 | Imepitoin | 1 |
| 188252-75-7 | Ketoprofen EP Impurity E (R-isomer) | 1 |
| 188259-69-0 | 4-Hydroxy Valsartan | 1 |
| 188260-51-7 | 3-[[4-(3-Pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 1 |
| 188264-84-8 | (S,S)-(+)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II), 99% | 1 |
| 188295-03-6 | Dimethidene-N-Oxide | 1 |
| 188397-16-2 | N-(2-(5-Methoxy-2-oxoindolin-3-yl)ethyl)acetamide | 1 |
| 188399-46-4 | ent-Entecavir | 1 |
| 188416-20-8 | Rac-6-Chloro Voriconazole Hydrochloride | 1 |
| 188416-28-6 | Voriconazole Imp (VNZ-1) (st-I) | 1 |
| 188416-29-7 | Ent-Voriconazole | 1 |
| 188416-34-4 | Voriconazole camphor sulphonic acid salt | 1 |
| 188416-35-5 | Rac-6-Chloro Voriconazole | 1 |
| 188416-44-6 | 3-(6-Chloropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 1 |
| 188416-47-9 | 4-(1-Bromoethyl)-5-fluoropyrimidine | 1 |
| 188425-85-6 | Boscalid | 1 |
| 188612-53-5 | 5-Amino-1-(N-Methyl carbamoyl) Imidazole-4-carboxamide | 1 |
| 188627-80-7 | Eptifibatide | 1 |
| 188649-48-1 | 3-((Butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | 1 |
| 188655-38-1 | Hexetidine EP Impurity A | 1 |
| 188659-43-0 | (2R,4R)-1-((2S)-5-Amino-2-((3-methyl-1,2,3,4-tetrahydroquinoline)-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic Acid | 1 |
| 188666-11-7 | Nizatidine EP Impurity E | 1 |
| 188690-82-6 | (R)-1-(4-(Benzyloxy)-3-nitrophenyl)-2-bromoethan-1-ol | 1 |
| 188690-83-7 | N-(5-((R)-2-(Benzyl((R)-1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)-2-(benzyloxy)phenyl)formamide | 1 |
| 188717-17-1 | Montelukast acyl-Beta-D-glucuronide | 1 |
| 188779-13-7 | (2S,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol | 1 |
| 188797-76-4 | Ziprasidone N-Oxide | 1 |
| 188797-77-5 | Ziprasidone Sulfone | 1 |
| 188797-79-7 | 6-Chloro-5-(2-(piperazin-1-yl)ethyl)indolin-2-one | 1 |
| 188797-80-0 | Ziprasidone Sulfoxide | 1 |
| 188904-84-9 | Methylene Methanone Impurity | 1 |
| 188904-85-0 | Mixture of (2R,3S) & (2S,3R) Efinaconazole | 1 |
| 188915-50-6 | Cefaclor EP Impurity E | 1 |
| 189005-44-5 | Zolpidic acid | 1 |
| 189016-90-8 | Naltrexone EP Impurity C | 1 |
| 189028-93-1 | 3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4(S)-phenyl-2-oxazolidinone | 1 |
| 189028-95-3 | (4S)-4-Phenyl-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one | 1 |
| 189038-36-6 | Linezolid N-Oxide | 1 |
| 189153-10-4 | Boc-trans-4-aminocyclohexane acetic acid | 1 |
| 189188-57-6 | Tegaserod Maleate | 1 |
| 189241-28-9 | 8-Arginine Vasopressin Trisulphide | 1 |
| 189264-02-6 | (2S,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic Acid | 1 |
| 189264-03-7 | (2S,4S)-Argatroban | 1 |
| 189264-04-8 | (2R,4S)-1-(2S)-Argatroban | 1 |
| 189279-58-1 | Delafloxacin | 1 |
| 189337-28-8 | Fmoc-O-tert-butyl-L-threoninol, ≥98% (HPLC) | 1 |
| 189345-04-8 | (6R,7R)-7-((Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | 1 |
| 189345-52-6 | (6R,7R)-7-Amino-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct- 2-ene-2-carboxylate | 1 |
| 189628-37-3 | 5- Bromo-2 - Chlorobenzaldehyde | 1 |
| 189691-06-3 | Bremelanotide | 1 |
| 189745-28-6 | 5-(Chloromethyl)-2-methylpyrimidin-4-amine | 1 |
| 189746-15-4 | Tafenoquine Impurity 9 | 1 |
| 189746-19-8 | Tafenoquine Impurity 7 | 1 |
| 189746-21-2 | Tafenoquine Impurity 8 | 1 |
| 189950-11-6 | Trodat, 95% | 1 |
| 189954-96-9 | Firocoxib | 1 |
| 189955-22-4 | Firocoxib cyclobutane derivative | 1 |
| 189955-79-1 | 2-Bromo-2-methyl-1-[4-(methylsulfonyl)phenyl]-1-propanone | 1 |
| 189955-89-3 | 3-Hydroxy-5,5-dimethyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone | 1 |
| 189956-45-4 | 4-[(4-Oxo-1, 4-Dihydropyrimidin-2-yl)amino]-Benzonitrile | 1 |
| 190000-46-5 | Levomedetomidine Hydrochloride | 1 |
| 190448-46-5 | 3-O-Acetyl Ezetimibe | 1 |
| 190448-57-8 | Ezetimibe Phenoxy Glucuronide | 1 |
| 190595-65-4 | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one | 1 |
| 190595-66-5 | (3`S,3R,4S)-Desfluoro Ezetimibe | 1 |
| 190601-22-0 | (S)-3-(4-(2-Hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoic Acid | 1 |
| 190604-92-3 | Acetamiprid-N-desmethyl | 1 |
| 190605-03-9 | Rhein Acyl-beta-D-glucuronide | 1 |
| 190662-30-7 | Dienogest EP Impurity D | 1 |
| 190710-79-3 | N-Desmethyl Topotecan | 1 |
| 190728-24-6 | Cabozantinib Nitro Analog | 1 |
| 190728-25-7 | Cabozantinib Impurity 1 | 1 |
| 190728-26-8 | 6,7-Dimethoxy-4-(2-nitrophenoxy)quinoline | 1 |
| 190728-27-9 | 2-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline | 1 |
| 190730-39-3 | Bepotastine Ethyl ester | 1 |
| 190730-41-7 | (R)-Bepotastine | 1 |
| 190730-42-8 | (R)-Bepotastine Besylate | 1 |
| 190786-44-8 | Bepotastine Besilate | 1 |
| 190850-49-8 | Verapamil EP Impurity H | 1 |
| 190850-50-1 | Verapamil EP Impurity M HCl salt | 1 |
| 190910-14-6 | Neotame USP Related Compound A | 1 |
| 191085-33-3 | N-[2-(2-Chlorobenzoyl)-4-nitrophenyl]-2-[[[[2-(2-chlorobenzoyl)-4-nitrophenyl]carbamoyl]methyl]amino]acetamide | 1 |
| 191114-48-4 | Telithromycin | 1 |
| 191155-81-4 | 3-(2-(Trifluoromethyl)phenyl)propan-1-ol | 1 |
| 191162-39-7 | Quinoline-3-boronic acid, 97% | 1 |
| 191217-81-9 | Pramipexole Dihydrochloride Monohydrate | 1 |
| 191226-98-9 | [(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl[(4-nitro-phenyl)sulfonyl)]amino]propyl]-carbamic Acid tert-Butyl Ester | 1 |
| 191330-56-0 | Ezetimibe Ketone Impurity | 1 |
| 191474-13-2 | Anhydrothymidine-FLT-precursor {5'-O-(4,4'-Dimethoxytrityl)-2,3'-anhydrothymidine} | 1 |
| 191543-16-5 | 3`-Ethylpropiophenone | 1 |
| 191546-94-8 | Mirtazapine EP Impurity E | 1 |
| 191546-96-0 | Mirtazapine EP Impurity C | 1 |
| 191546-97-1 | Mirtazapine EP Impurity F | 1 |
| 191604-81-6 | Methyl-5-(hydroxymethyl)-2-methoxybenzoate | 1 |
| 191605-10-4 | Ruxolitinib Impurity-H | 1 |
| 191732-72-6 | Lenalidomide | 2 |
| 191732-74-8 | 5-Amino Lenalidomide | 1 |
| 191732-76-0 | 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline | 1 |
| 191864-24-1 | (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate | 1 |
| 191939-34-1 | Bendamustine USP Related Compound G | 1 |
| 192057-49-1 | Budesonide 17-Carboxylic Acid | 1 |
| 192118-08-4 | Glipizide EP Impurity F | 1 |
| 192118-19-7 | Enalaprilat EP Impurity D (Free Base) | 1 |
| 192139-90-5 | (S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II), 97% | 1 |
| 192139-92-7 | RuCl(p-cymene)[(R,R)-Ts-DPEN] | 1 |
| 192182-54-0 | 3,5-Dimethoxyphenylboronic acid, 98% | 1 |
| 192191-49-4 | Fluticasone Impurity 28 | 1 |
| 192191-51-8 | (6S,6'S,8S,8'S,9R,9'R,10S,10'S,11S,11'S,13S,13'S,14S,14'S,16R,16'R,17R,17'R)-((Methylenebis(sulfanediyl))bis(carbonyl))bis(6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17,17-diyl) Dipropionate | 1 |
| 192374-14-4 | (S,S)-Hydroxy Bupropion | 1 |
| 192374-15-5 | (R,R)-Hydroxy Bupropion | 1 |
| 192384-41-1 | Tramadol EP Impurity C | 1 |
| 192447-02-2 | 11-O-Formyl 21- Ethyl formate Dexamethasone | 1 |
| 192504-81-7 | Nicergoline EP Impurity H | 1 |
| 192704-56-6 | 11-Hydroxy Mexrenone | 1 |
| 192704-82-8 | Eplerenone EP Impurity B | 1 |
| 192725-17-0 | Lopinavir | 1 |
| 192725-39-6 | Lopinavir Metabolite M-1 | 1 |
| 192725-45-4 | tert-Butyl ((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | 1 |
| 192725-49-8 | Lopinavir EP Impurity E | 1 |
| 192725-50-1 | (S)-Tetrahydro-a-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic acid | 1 |
| 192725-55-6 | (3R,3AS,6aR)-hexahydrofuro[2,3-b]furan-3-yl 4-nitrophenyl carbonate | 1 |
| 192725-89-6 | (2S)-2-(2,4-Dioxohexahydropyrimidine-1-yl)-3-methylbutanoic acid | 1 |
| 192726-05-9 | Lopinavir EP Impurity A | 1 |
| 192770-68-6 | 1-Nitrosoindoline-2-carboxylic acid | 1 |
| 192775-97-6 | 2-(2-(4-Bromophenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | 1 |
| 192800-79-6 | 4-Amino-N-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide | 1 |
| 192802-33-8 | Acyclovir Potassium | 1 |
| 192876-02-1 | Fluvoxamine EP Impurity G | 1 |
| 192885-13-5 | Fexofenadine Impurity 9 | 1 |
| 192927-63-2 | Moxifloxacin Hydrochloride Monohydrate | 1 |
| 193013-72-8 | 2-Tert-Butylbenzenesulfonamide | 1 |
| 193140-43-1 | 2-Pentanimidamidoacetic Acid | 1 |
| 193146-85-9 | rac-Galanthamine Hydrobromide | 1 |
| 193265-47-3 | 4-[2-(2-Amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid | 1 |
| 193275-84-2 | Lonafarnib | 1 |
| 193275-85-3 | Lonafarnib S-Enantiomer | 1 |
| 193276-16-3 | Des-10-Bromo Lonafarnib | 1 |
| 193276-77-6 | Lonafarnib Impurity 1 | 1 |
| 193281-00-4 | Pemetrexed 6-Oxo Diacid Impurity | 1 |
| 193281-05-9 | Pemetrexed Impurity 19 | 1 |
| 193290-55-0 | Zafirlukast Di Bromo Stage-1 | 1 |
| 193526-90-8 | Maribavir Chloromethyl Impurity | 1 |
| 193618-59-6 | L-Arg(1)-Icatibant | 1 |
| 193686-76-9 | 7-Chloro-1-tosyl-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one | 1 |
| 193740-38-4 | Des-L-Arg(2)-Icatibant | 1 |
| 193979-22-5 | Eltrombopag Olamine Lactose Adduct Impurity | 1 |
| 194023-72-8 | Marbofloxacin EP Impurity F | 1 |
| 194039-81-1 | Bis((1,1,1,3,3,3-Hexafluoropropan-2-yl)oxy)methane | 1 |
| 194039-83-3 | 1,1,1,3,3,3-Hexafluoro-2-((((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)methoxy)methoxy)propane | 1 |
| 194154-40-0 | Valganciclovir N-Benzyloxycarbonyl Impurity | 1 |
| 194159-18-7 | Ganciclovir EP Impurity B | 1 |
| 194159-22-3 | Valganciclovir O-Acetyl N-Benzyloxycarbonyl Impurity | 1 |
| 194241-83-3 | Ceftazidime EP Impurity G | 1 |